최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국식품영양과학회지 = Journal of the Korean Society of Food Science and Nutrition, v.43 no.4, 2014년, pp.498 - 506
박연실 (부안군농업기술센터) , 강성선 (부안군농업기술센터) , 최형자 (부안군농업기술센터) , 양성준 (부안군농업기술센터) , 손호형 ((주)벤스랩) , 서형호 ((주)벤스랩) , 정종문 ((주)벤스랩)
The objective of this study was to investigate the beneficial effects of mulberry extract (MBE) on blood flow improvement. The
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
오디의 이명은? | 오디는 상심자, 상심, 상실, 오심이라고도 불리며 뽕나무과(Moraceae), 뽕나무속(Morus)에 속하는 뽕나무(Morus alba L.)의 열매로서 식품공전에서 주원료(열매, 잎, 어린가지)로 식품에 사용 가능한 동식물로 분류된다. | |
이상지질혈증 외에 혈액순환장애를 유발하는 인자와 관련된 것은 무엇인가? | 혈액순환장애를 유발하는 인자들 중에서 이상지질혈증은 total cholesterol, triglyceride 및 LDL-cholesterol이 정상보다 혈중농도가 높은 경우나 HDL-cholesterol이 정상보다 혈중농도가 낮은 경우이다(15). 또한 체내 cholesterol 합성을 조절하는 효소인 HMG-CoA 환원효소(3-hydroxy3-methyl glutaryl-coenzyme A reductase, HMGR)의 활성화(16), 혈관협착을 유발하는 세포 간 접착분자인 ICAM1(inter cellular adhesion molecule-1) 및 VCAM-1(vascular cell adhesion molecule-1)의 생성 증가(17), 동맥경화증에서 정상보다 높게 나타나는 염증지표인자인 혈중 C-reactive protein의 농도(18), 혈전형성에 관여하는 물질인 thromboxane A2(19), 대식세포와 같은 염증세포의 활성으로 동맥경화증의 진행 및 죽상판의 취약성에 관여하는 효소인 COX-2(cycloxygenase-2)(20) 및 혈전의 형성과 확대에 관련된 LDL(low density lipoprotein)의 산화(21) 등이 혈액순환장애에 관련되어 있다. | |
혈액순환장애의 원인은? | 혈액순환장애는 혈액이나 림프액의 순환에 장애가 생기는 질병이며 원인으로는 당뇨, 고혈압, 이상지질혈증, 고연령, 가족력, 흡연, 비만, 운동부족 및 스트레스 등이 있으며(9,10), 관련된 질환으로는 고혈압, 협심증, 심근경색증, 관상동맥경화증, 고지혈증, 뇌졸중 및 뇌출혈 등이 있다(11-14). 혈액순환장애를 유발하는 인자들 중에서 이상지질혈증은 total cholesterol, triglyceride 및 LDL-cholesterol이 정상보다 혈중농도가 높은 경우나 HDL-cholesterol이 정상보다 혈중농도가 낮은 경우이다(15). |
Park SW, Jung YS, Ko KC. 1997. Quantitative analysis of anthocyanins among mulberry cultivars and their pharmacological screening. Hortic Environ Biotechnol 38: 722-724.
Kim HB, Kim SL. 2003. Identification of C3G (cyanidin-3 glucoside) from mulberry fruits and quantification with different varieties. Korean J Seric Sci 45: 90-95.
Kim HB, Kim AJ, Kim SY. 2003. The analysis of functional materials in mulberry fruit and food product development trends. Food Sci Ind 36: 49-60.
Kim MH, Ko KC, Lim SH, Yu YS. 1980. Study on the usability of mulberry fruit. Fruit characteristics of mulberry. Coll of Agric Bull SNU 5: 221-223.
Kim TW, Kwon YB, Lee JH, Yang IS, Youm JK, Lee HS, Moon JY. 1996. A study on the antidiabetic effect of mulberry fruits. Korean J Seric Sci 38: 100-107.
Kim HY, Park JY. 2000. Oxidative stress and atherosclerosis. J Korean Soc Endocrinol 15: 1-14.
Lutgens E, van Suylen RJ, Faber BC, Gijbels MJ, Eurlings PM, Bijnens AP, Cleutjens KB, Heeneman S, Daemen MJ. 2003. Atherosclerotic plaque rupture: local or systemic process? Arterioscler Thromb Vasc Biol 23: 2123-2130.
Ross R. 1999. Atherosclerosis-an inflammatory disease. New Engl J Med 340: 115-126.
Libby P, Ridker PM, Maseri A. 2002. Inflammation and atherosclerosis. Circulation 105: 1135-1143.
Kockx MM, Cromheeke KM, Knaapen MW, Bosmans JM, De Meyer GR, Herman AG, Bult H. 2003. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 23: 440-446.
Moreno PR, Purushothaman KR, Fuster V, Echeverri D, Truszczynska H, Sharma SK, Badimon JJ, O'Connor WN. 2004. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 110: 2032-2038.
Topper JN, Cai J, Falb D, Gimbrone MA Jr. 1996. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A 93: 10417-10422.
Dichtl W, Nilsson L, Goncalves I, Ares MP, Banfi C, Calara F, Hamsten A, Eriksson P, Nilsson J. 1999. Very low-density lipoprotein activates nuclear factor- ${\kappa}B$ in endothelial cells. Circ Res 84: 1085-1094.
Kiener PA, Davis PM, Murray JL, Youssef S, Rankin BM, Kowala M. 2001. Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors. Int Immunopharmacol 1: 105-118.
Nagel T, Resnick N, Atkinson WJ, Dewey CF Jr, Gimbrone MA Jr. 1994. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest 94: 885-891.
Libby P, Simon DI. 2001. Inflammation and thrombosis: the clot thickens. Circulation 103: 1718-1720.
Racz A, Veresh Z, Lotz G, Bagi Z, Koller A. 2010. Cyclooxygenase-2 derived thromboxane A2 and reactive oxygen species mediate flow-induced constrictions of venules in hyperhomocysteinemia. Atherosclerosis 208: 43-49.
Nodai A, Machida T, Izumi S, Hamaya Y, Kohno T, Igarashi Y, Iizuka K, Minami M, Hirafuji M. 2007. Sphingosine 1-phosphate induces cyclooxygenase-2 via $Ca^{2+}$ -dependent, but MAPK-independent mechanism in rat vascular smooth muscle cells. Life Sci 80: 1768-1776.
Stemme S, Faber B, Holm J, Witztum JL, Hansson GK. 1995. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A 92: 3893-3897.
Sladowski D, Steer SJ, Clothier RH, Balls M. 1993. An improved MTT assay. J Immunol Methods 157: 203-207.
Ames BN, Shigenaga MK, Hagen TM. 1993. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 90: 7915-7922.
Jacob S, Laury-Kleintop L, Lanza-Jacoby S. 2008. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice. J Surg Res 146: 135-142.
Gabriel AB, Wulf H, Anne B, Roland S, Klaus AD, Hans PD, Wulf D, Jurgen M, Ralf K. 2005. Increased cyclooxygenase- 2 expression in peripheral blood mononuclear cells of smokers and hyperlipidemic subjects. Free Radic Biol Med 38: 235-242.
Tsukasa N, Chifuyu U, Shiori O, Teruo I, Noriaki S, Hikaru K. 2003. Effect of low-density lipoprotein apheresis on plasma endothelin-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans. J Diabetes Complications 17: 349-354.
Fuhrman B, Judith O, Keidar S, Ben-Yaish L, Kaplan M, Aviram M. 1997. Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. Free Radic Biol Med 23: 34-46.
Perez-Jimenez F, Lopez-Miranda J, Mata P. 2002. Protective effect of dietary monounsaturated fat on arteriosclerosis: beyond cholesterol. Atherosclerosis 163: 385-398.
Rosenblat M, Oren R, Aviram M. 2006. Lysophosphatidylcholine (LPC) attenuates macrophage-mediated oxidation of LDL. Biochem Biophys Res Commun 344: 1271-1277.
Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E. 1997. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96 : 4219-4225.
Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. 1993. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 13: 197-204.
Utsumi K, Kawabe M, Hirama A, Ueda K, Kamada Y, Arii K, Komaba Y, Katsura K, Iino Y, Katayama Y. 2007. Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis. Clin Chim Acta 377: 198-200.
Schmidt A, Goepfert C, Feitsma K, Buddecke E. 2002. Lovastatin-stimulated superinduction of E-selectin, ICAM-1 and VCAM-1 in TNF-alpha activated human vascular endothelial cells. Atherosclerosis 164: 57-64.
Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB. 1999. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middleaged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99: 237-242.
Mendall MA, Strachan DP, Butland BK, Ballam L, Morris J, Sweetnam PM, Elwood PC. 2000. C-Reactive protein: relation to total mortality, cardiovascular mortality, and cardiovascular risk factors in men. Eur Heart J 21: 1584-1590.
Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, Summaria F, Ginnetti F, Fadda G, Maseri A. 1999. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99: 855-860.
Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH. 1997. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17: 1121-1127.
Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. 1998. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98: 731-733.
Danenberg HD, Szalai AJ, Swaminathan RV, Peng L, Chen Z, Seifert P, Fay WP, Simon DI, Edelman ER. 2003. Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation 108: 512-515.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.